BACKGROUND: Patients report information deficits in the period surrounding diagnosis of multiple sclerosis (MS). We assessed the effectiveness of an add-on information aid for newly diagnosed MS patients. METHODS: We randomly assigned 120 newly diagnosed MS patients from five Italian centres to diagnosis disclosure (current practice at the centre) or current practice plus information aid (ISRCTN81072971). The information aid consisted of a personal interview with a physician using a navigable compact disc and a take-home booklet. The primary composite endpoint was score in the highest tertile of MS knowledge and satisfaction with care questionnaires. Other endpoints were safety; treatment adherence; extra contacts/consultations; switching of care centre; and changes in Hospital Anxiety and Depression Scale and Control Preference Scale scores. RESULTS: At 1 month, 30/60 intervention and 8/60 control patients achieved the primary endpoint (odds ratio [OR] 6.5, 95% CI 2.6-16.0; p < 0.001; number needed to treat [NNT] 3). Figures at 6 months were 26/60 intervention and 11/60 control patients (OR 3.4, 95% CI 1.5-7.8; p = 0.04; NNT 4). There were no adverse events. No significant treatment effects were seen on secondary outcomes. CONCLUSION: The information aid was safe and significantly associated with attainment of the primary outcome at 1 and 6 months.
RCT Entities:
BACKGROUND:Patients report information deficits in the period surrounding diagnosis of multiple sclerosis (MS). We assessed the effectiveness of an add-on information aid for newly diagnosed MSpatients. METHODS: We randomly assigned 120 newly diagnosed MSpatients from five Italian centres to diagnosis disclosure (current practice at the centre) or current practice plus information aid (ISRCTN81072971). The information aid consisted of a personal interview with a physician using a navigable compact disc and a take-home booklet. The primary composite endpoint was score in the highest tertile of MS knowledge and satisfaction with care questionnaires. Other endpoints were safety; treatment adherence; extra contacts/consultations; switching of care centre; and changes in Hospital Anxiety and Depression Scale and Control Preference Scale scores. RESULTS: At 1 month, 30/60 intervention and 8/60 control patients achieved the primary endpoint (odds ratio [OR] 6.5, 95% CI 2.6-16.0; p < 0.001; number needed to treat [NNT] 3). Figures at 6 months were 26/60 intervention and 11/60 control patients (OR 3.4, 95% CI 1.5-7.8; p = 0.04; NNT 4). There were no adverse events. No significant treatment effects were seen on secondary outcomes. CONCLUSION: The information aid was safe and significantly associated with attainment of the primary outcome at 1 and 6 months.
Authors: Christian Philipp Kamm; L Barin; C Gobbi; C Pot; P Calabrese; A Salmen; L Achtnichts; J Kesselring; M A Puhan; V von Wyl Journal: J Neurol Date: 2019-10-08 Impact factor: 4.849
Authors: Elena Álvarez-Rodríguez; César Manuel Sánchez-Franco; María José Pérez-Haro; Laura Bello-Otero; Marta Aguado-Valcarcel; Inés González-Suárez Journal: PLoS One Date: 2022-05-13 Impact factor: 3.752
Authors: Anne Christin Rahn; Alessandra Solari; Heleen Beckerman; Richard Nicholas; David Wilkie; Christoph Heesen; Andrea Giordano Journal: Int J MS Care Date: 2020-12-28
Authors: Peter Rieckmann; Alexey Boyko; Diego Centonze; Alasdair Coles; Irina Elovaara; Eva Havrdová; Otto Hommes; Jacques Lelorier; Sarah A Morrow; Celia Oreja-Guevara; Nick Rijke; Sven Schippling Journal: J Neurol Date: 2012-08-31 Impact factor: 4.849
Authors: Sophie Hill; Graziella Filippini; Anneliese Synnot; Michael Summers; Deirdre Beecher; Cinzia Colombo; Paola Mosconi; Mario A Battaglia; Sue Shapland; Richard H Osborne; Melanie Hawkins Journal: BMC Med Inform Decis Mak Date: 2012-03-16 Impact factor: 2.796